Reports Q3 revenue $371.5M, consensus $366.9M. Katie Szyman, Chief Executive Officer of Masimo (MASI), said, “In the third quarter, we saw continued positive momentum across our core healthcare business, driven by the power of our innovative products. Revenues grew 8%, operating margin improved by 450 basis points, and EPS grew by 38%, all driven by sales growth and our successful operating efficiency initiatives. During the quarter, we closed the sale of Sound United to Harman and used the net proceeds to repurchase common stock. We also announced the expansion of our strategic partnership with Philips. We continue to invest in our core healthcare business to position for strong, sustainable long-term growth, and look forward to sharing more details on our strategy and innovations at our upcoming Investor Day on December 3rd.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MASI:
- Masimo Corp. (MASI) Q3 Earnings Cheat Sheet
- Masimo’s Study on Pulse Oximetry and Skin Pigmentation: A Potential Game-Changer
- Masimo Corp. Explores New Frontiers in Sleep Therapy with PROSOMNIA Study
- Masimo Sells Sound United to HARMAN for $328M
- Masimo renewal, expansion with Philips ‘clearly positive news,’ says Stifel